Logo image of LHYFE.PA

LHYFE SAS (LHYFE.PA) Stock Fundamental Analysis

EPA:LHYFE - Euronext Paris - Matif - FR0014009YQ1 - Common Stock - Currency: EUR

3.44  -0.04 (-1.15%)

Fundamental Rating

3

LHYFE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 61 industry peers in the Oil, Gas & Consumable Fuels industry. LHYFE has a bad profitability rating. Also its financial health evaluation is rather negative. LHYFE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LHYFE has reported negative net income.
LHYFE had a negative operating cash flow in the past year.
In the past 5 years LHYFE always reported negative net income.
LHYFE had a negative operating cash flow in each of the past 5 years.
LHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFLHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -13.08%, LHYFE is not doing good in the industry: 91.53% of the companies in the same industry are doing better.
With a Return On Equity value of -40.50%, LHYFE is not doing good in the industry: 91.53% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.08%
ROE -40.5%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHYFE.PA Yearly ROA, ROE, ROICLHYFE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

The Gross Margin of LHYFE (82.53%) is better than 88.14% of its industry peers.
In the last couple of years the Gross Margin of LHYFE has grown nicely.
The Profit Margin and Operating Margin are not available for LHYFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
LHYFE.PA Yearly Profit, Operating, Gross MarginsLHYFE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

2

2. Health

2.1 Basic Checks

LHYFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LHYFE has about the same amount of shares outstanding.
LHYFE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LHYFE is higher compared to a year ago.
LHYFE.PA Yearly Shares OutstandingLHYFE.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LHYFE.PA Yearly Total Debt VS Total AssetsLHYFE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.08, we must say that LHYFE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.08, LHYFE is not doing good in the industry: 86.44% of the companies in the same industry are doing better.
LHYFE has a Debt/Equity ratio of 0.97. This is a neutral value indicating LHYFE is somewhat dependend on debt financing.
The Debt to Equity ratio of LHYFE (0.97) is worse than 74.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC7.68%
LHYFE.PA Yearly LT Debt VS Equity VS FCFLHYFE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

LHYFE has a Current Ratio of 1.86. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LHYFE (1.86) is better than 61.02% of its industry peers.
LHYFE has a Quick Ratio of 1.86. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
LHYFE's Quick ratio of 1.86 is fine compared to the rest of the industry. LHYFE outperforms 72.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.86
LHYFE.PA Yearly Current Assets VS Current LiabilitesLHYFE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

7

3. Growth

3.1 Past

LHYFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.12%, which is quite good.
LHYFE shows a strong growth in Revenue. In the last year, the Revenue has grown by 287.17%.
The Revenue has been growing by 195.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.06%
Revenue 1Y (TTM)287.17%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%268.49%

3.2 Future

Based on estimates for the next years, LHYFE will show a very strong growth in Earnings Per Share. The EPS will grow by 27.21% on average per year.
The Revenue is expected to grow by 129.95% on average over the next years. This is a very strong growth
EPS Next Y0.52%
EPS Next 2Y30.4%
EPS Next 3Y27.21%
EPS Next 5YN/A
Revenue Next Year354.96%
Revenue Next 2Y335.52%
Revenue Next 3Y207.51%
Revenue Next 5Y129.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LHYFE.PA Yearly Revenue VS EstimatesLHYFE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
LHYFE.PA Yearly EPS VS EstimatesLHYFE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LHYFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LHYFE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHYFE.PA Price Earnings VS Forward Price EarningsLHYFE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHYFE.PA Per share dataLHYFE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as LHYFE's earnings are expected to grow with 27.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.4%
EPS Next 3Y27.21%

More info and screens

0

5. Dividend

5.1 Amount

LHYFE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LHYFE SAS

EPA:LHYFE (7/11/2025, 7:00:00 PM)

3.44

-0.04 (-1.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners9.23%
Inst Owner ChangeN/A
Ins Owners3.29%
Ins Owner ChangeN/A
Market Cap165.02M
Analysts81.67
Price Target5.18 (50.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-21.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.36
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 3.08
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0.11
BVpS1.5
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.08%
ROE -40.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.53%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 745.26%
Cap/Sales 687.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.86
Altman-Z -0.08
F-Score5
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)957.78%
Cap/Depr(5y)2682.27%
Cap/Sales(3y)1925.18%
Cap/Sales(5y)13341.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.06%
EPS Next Y0.52%
EPS Next 2Y30.4%
EPS Next 3Y27.21%
EPS Next 5YN/A
Revenue 1Y (TTM)287.17%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%268.49%
Revenue Next Year354.96%
Revenue Next 2Y335.52%
Revenue Next 3Y207.51%
Revenue Next 5Y129.95%
EBIT growth 1Y15.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.74%
EBIT Next 3Y36.05%
EBIT Next 5Y27.12%
FCF growth 1Y1.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.3%
OCF growth 3YN/A
OCF growth 5YN/A